ArticleThe Journal of clinical investigation2024

Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma.

Shashwat Tripathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.